Literature DB >> 28674182

Mesenchymal Cell-Specific MyD88 Signaling Promotes Systemic Dissemination of Salmonella Typhimurium via Inflammatory Monocytes.

Donghyun Kim1,2,3, Sang-Uk Seo1,2,4, Melody Y Zeng1,2, Wan-Uk Kim3,5, Nobuhiko Kamada6, Naohiro Inohara1, Gabriel Núñez7,2.   

Abstract

Enteric pathogens including Salmonella enteric serovar Typhimurium can breach the epithelial barrier of the host and spread to systemic tissues. In response to infection, the host activates innate immune receptors via the signaling molecule MyD88, which induces protective inflammatory and antimicrobial responses. Most of these innate immune responses have been studied in hematopoietic cells, but the role of MyD88 signaling in other cell types remains poorly understood. Surprisingly, we found that Dermo1-Cre;Myd88fl/fl mice with mesenchymal cell-specific deficiency of MyD88 were less susceptible to orogastric and i.p. STyphimurium infection than their Myd88fl/fl littermates. The reduced susceptibility of Dermo1-Cre;Myd88fl/fl mice to infection was associated with lower loads of S. Typhimurium in the liver and spleen. Mutant analyses revealed that S. Typhimurium employs its virulence type III secretion system 2 to promote its growth through MyD88 signaling pathways in mesenchymal cells. Inflammatory monocytes function as a major cell population for systemic dissemination of S. Typhimurium Mechanistically, mesenchymal cell-specific MyD88 signaling promoted CCL2 production in the liver and spleen and recruitment of inflammatory monocytes to systemic organs in response to STyphimurium infection. Consistently, MyD88 signaling in mesenchymal cells enhanced the number of phagocytes including Ly6ChiLy6G- inflammatory monocytes harboring STyphimurium in the liver. These results suggest that S. Typhimurium promotes its systemic growth and dissemination through MyD88 signaling pathways in mesenchymal cells.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28674182      PMCID: PMC5548622          DOI: 10.4049/jimmunol.1601527

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  Mesenchymal cells of the intestinal lamina propria.

Authors:  D W Powell; I V Pinchuk; J I Saada; Xin Chen; R C Mifflin
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

2.  Mesodermal Pten inactivation leads to alveolar capillary dysplasia- like phenotype.

Authors:  Caterina Tiozzo; Gianni Carraro; Denise Al Alam; Sheryl Baptista; Soula Danopoulos; Aimin Li; Maria Lavarreda-Pearce; Changgong Li; Stijn De Langhe; Belinda Chan; Zea Borok; Saverio Bellusci; Parviz Minoo
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

3.  The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms.

Authors:  Siegfried Hapfelmeier; Bärbel Stecher; Manja Barthel; Marcus Kremer; Andreas J Müller; Mathias Heikenwalder; Thomas Stallmach; Michael Hensel; Klaus Pfeffer; Shizuo Akira; Wolf-Dietrich Hardt
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

4.  Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis.

Authors:  Bryan Coburn; Yuling Li; David Owen; Bruce A Vallance; B Brett Finlay
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  Disruption of the Salmonella-containing vacuole leads to increased replication of Salmonella enterica serovar typhimurium in the cytosol of epithelial cells.

Authors:  John H Brumell; Patrick Tang; Michelle L Zaharik; B Brett Finlay
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  Toll-like receptor-deficient mice reveal how innate immune signaling influences Salmonella virulence strategies.

Authors:  Kelsey E Sivick; Nicholas Arpaia; Gabrielle L Reiner; Bettina L Lee; Bethany R Russell; Gregory M Barton
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

8.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

9.  Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines.

Authors:  I B Autenrieth; V Kempf; T Sprinz; S Preger; A Schnell
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

10.  Salmonella uses energy taxis to benefit from intestinal inflammation.

Authors:  Fabian Rivera-Chávez; Sebastian E Winter; Christopher A Lopez; Mariana N Xavier; Maria G Winter; Sean-Paul Nuccio; Joseph M Russell; Richard C Laughlin; Sara D Lawhon; Torsten Sterzenbach; Charles L Bevins; Renée M Tsolis; Rasika Harshey; L Garry Adams; Andreas J Bäumler
Journal:  PLoS Pathog       Date:  2013-04-18       Impact factor: 6.823

View more
  2 in total

1.  Salmonella enterica Serovar Typhimurium Travels to Mesenteric Lymph Nodes Both with Host Cells and Autonomously.

Authors:  Alberto Bravo-Blas; Lotta Utriainen; Slater L Clay; Verena Kästele; Vuk Cerovic; Adam F Cunningham; Ian R Henderson; Daniel M Wall; Simon W F Milling
Journal:  J Immunol       Date:  2018-11-28       Impact factor: 5.422

2.  RIPK3-Dependent Recruitment of Low-Inflammatory Myeloid Cells Does Not Protect from Systemic Salmonella Infection.

Authors:  John Satkovich; Christopher J Anderson; Christopher B Medina; Matteo Ottolini; John R Lukens; Melissa M Kendall
Journal:  mBio       Date:  2020-10-06       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.